Site-specific effects of dietary salt intake on guanylin and uroguanylin mRNA expression in rat intestine
- PMID: 12137970
- DOI: 10.1016/s0167-0115(02)00069-1
Site-specific effects of dietary salt intake on guanylin and uroguanylin mRNA expression in rat intestine
Abstract
Guanylin and uroguanylin are newly discovered intestinal peptides that have been shown to affect NaCl transport in both the intestine and kidney. The present study tests the hypothesis that guanylin and uroguanylin mRNA expression in each major region of the intestine is regulated by NaCl intake. Semiquantitative multiplex RT-PCR analysis was used to determine the molecular expression of guanylin and uroguanylin in the duodenum, jejunum, ileum, and colon in rats maintained on low (LS), normal (NS), or high (HS) NaCl intake for 4 days. LS intake reduced the expression of uroguanylin, and to a lesser degree, guanylin mRNA in all intestinal segments compared to NS intake. The duodenum was the site of the greatest decrease for both. In contrast, HS intake significantly increased the expression of guanylin mRNA only in the duodenum and jejunum and had minimal effect on uroguanylin mRNA. The minimum time required for altered gene expression was determined by delivering an oral NaCl challenge directly to the gastrointestinal tract by oro-gastric administration to LS or NS animals. In LS rats, NaCl oro-gastric administration significantly increased mRNA expression of both peptides in all intestinal segments. Furthermore, the increases in guanylin and uroguanylin mRNA were detected within 4 h and plateaued by 8 h. Conversely, acute oro-gastric administration of the same NaCl solution to NS rats caused elevations of guanylin mRNA only in the duodenum and jejunum, and of uroguanylin mRNA only in the ileum and colon. In conclusion, the data demonstrate that variations in NaCl intake lead to intestinal segment-specific changes in guanylin and uroguanylin mRNA expression.
Similar articles
-
High salt intake increases uroguanylin expression in mouse kidney.Endocrinology. 2001 Jul;142(7):3087-97. doi: 10.1210/endo.142.7.8274. Endocrinology. 2001. PMID: 11416031
-
Cloning and mRNA expression of guanylin, uroguanylin, and guanylyl cyclase C in the Spinifex hopping mouse, Notomys alexis.Gen Comp Endocrinol. 2003 Jun 1;132(1):171-9. doi: 10.1016/s0016-6480(03)00082-0. Gen Comp Endocrinol. 2003. PMID: 12765657
-
Structure and activity of uroguanylin and guanylin from the intestine and urine of rats.Am J Physiol. 1997 Nov;273(5):E957-64. doi: 10.1152/ajpendo.1997.273.5.E957. Am J Physiol. 1997. PMID: 9374682
-
Salt and water homeostasis: uroguanylin is a circulating peptide hormone with natriuretic activity.Am J Kidney Dis. 1996 Aug;28(2):296-304. doi: 10.1016/s0272-6386(96)90318-2. Am J Kidney Dis. 1996. PMID: 8768930 Review.
-
Guanylin regulatory peptides: structures, biological activities mediated by cyclic GMP and pathobiology.Regul Pept. 1999 May 31;81(1-3):25-39. doi: 10.1016/s0167-0115(99)00033-6. Regul Pept. 1999. PMID: 10395405 Review.
Cited by
-
CFTR High Expresser Cells in cystic fibrosis and intestinal diseases.Heliyon. 2023 Mar 14;9(3):e14568. doi: 10.1016/j.heliyon.2023.e14568. eCollection 2023 Mar. Heliyon. 2023. PMID: 36967909 Free PMC article. Review.
-
Guanylyl cyclase/natriuretic peptide receptor-A: Identification, molecular characterization, and physiological genomics.Front Mol Neurosci. 2023 Jan 4;15:1076799. doi: 10.3389/fnmol.2022.1076799. eCollection 2022. Front Mol Neurosci. 2023. PMID: 36683859 Free PMC article. Review.
-
Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities.Front Endocrinol (Lausanne). 2022 Jun 29;13:911459. doi: 10.3389/fendo.2022.911459. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846281 Free PMC article. Review.
-
Synergistic Effect of Uroguanylin and D1 Dopamine Receptors on Sodium Excretion in Hypertension.J Am Heart Assoc. 2022 Mar 15;11(6):e022827. doi: 10.1161/JAHA.121.022827. Epub 2022 Mar 1. J Am Heart Assoc. 2022. PMID: 35229618 Free PMC article.
-
Uroguanylin increases Ca2+ concentration in astrocytes via guanylate cyclase C-independent signaling pathway.Croat Med J. 2021 Jun 30;62(3):250-263. doi: 10.3325/cmj.2021.62.250. Croat Med J. 2021. PMID: 34212562 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
